Flora Hammond, MD (PI), James Malec, PhD (Co-PI), Jacob Kean, PhD, Susan Perkins, PhD, Patrick Monahan, PhD, funded by National Institute on Disability and Rehabilitation Research (NIDRR).
PURPOSE OF PROJECT: To study the effect expressed by persons with TBI through assessment of buspirone effectiveness for post-traumatic irritability and aggression and development of an irritability/aggression impact measure.
SUMMARY OF PROJECT: It is anticipated that 74 subjects with 74 corresponding subject observers will be recruited for the treatment study. Subjects will be recruited from community and self-referrals.
Contact Person: Becky Runkel, at email@example.com , or at (317) 329-2217.
Title: 2013 RHI Sports Visions of Victory Gala
Location: Murat Egyptian Room at Old National Centre
Description: 2013 RHI Sports Visions of Victory Gala
Saturday, April 20, 2013
Murat Egyptian Room at Old National Centre
502 N. New Jersey St.
Indianapolis, IN 46204
5:30pm – Cocktails and Silent Auction
7:00pm – Dinner and Victory Award Winner Presentation
8:15pm – Casino Games, Prizes, and Silent Auction
$50 – One Individual Ticket
$40 – One Individual Child Ticket (Comes w/kid friendly meal)
$40 – One Individual Ticket for RHI Employee
$35 – One Individual Ticket for RHI Sports Program Athlete/Family
$750 – One Corporate Table Sponsorship for 8 Guests
Many sponsorship opportunities available! Contact RHI Sports for more information.
317-329-2281 or firstname.lastname@example.org.
Start Time: 05:30pm
End Time: 10:00pm
Title: 9th Annual “An Outing to Remember” Location: River Glen Country Club
Description: 9th annual “An Outing to Remember” benefitting the Dr. Lisa Thompson Center for Family Education at the Rehabilitation Hospital of Indiana. 18-hole Scramble; Lunch, dinner, snacks and beverages; and Silent and live auctions, golf prizes and raffle.
Start Time: 11:30 am
End Time: 8:00 pm
James Malec, Ph.D. – Principal Investigator
The purpose of RHI’s Research Participant Registry is to create a RHI Research Participant Registry of individuals who are interested in participating or who have consented to participate in research at Rehabilitation Hospital of Indiana (RHI). Development of the Research Participant Registry will allow RHI researchers to:
1) examine participants’ demographic information across on-going and completed studies,
2) allow for future contact of registered participants, and
3) track participation statistics across studies (e.g., enrollment rates, attrition rates).
All individuals who are or have been inpatients or outpatients at RHI or who consent to participate in a research study at RHI will be given the opportunity to join the registry.
Contact Person: John McCreary, at email@example.com , or by phone at (317)313-3690.
Brenna McDonald, Psy.D., Flora Hammond, MD, Gwen Sprehn, Ph.D. Funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
A randomized, placebo-controlled, double-blind design, comparing the efficacy of three interventions: memory and attention training (MAAT), methylphenidate, and memory/attention training in combination with methylphenidate.
Traumatic brain injury (TBI) is a significant public health problem, with 1.5-2.0 million Americans injured each year. Cognitive deficits, particularly in the domains of memory and attention are frequently the source of lingering disability after TBI and a source of enormous distress to the injured individuals and their family/caregivers. To date, interventions to ameliorate chronic cognitive deficits have been directed at either pharmacological interventions or cognitive rehabilitation. We propose to (1) To compare the efficacy of three interventions: memory and attention training (MAAT), methylphenidate, and memory/attention training in combination with methylphenidate and (2) use functional MRI (fMRI) to characterize changes in activation of the neural circuitry of memory and attention due to MAAT alone, methylphenidate alone, and MAAT in combination with methylphenidate. This is a two by two design with medication (methylphenidate/placebo) and cognitive therapy (Memory and Attention Training (MAAT) or an Attention control intervention) as possible interventions. Using a randomized, placebo-controlled, double-blind design, 200 individuals with persistent cognitive deficits 6-12 months after MTBI will be randomized to receive a six week trial of either (1) MAAT and placebo, (2) MAAT and methylphenidate (0.3 mg/kg BID), (3) attention control intervention and methylphenidate (0.3 mg/kg BID), or (4) attention control intervention and placebo. Symptom distress, attention and memory performance, and activation patterns of the neural circuitry of attention and memory while undergoing fMRI will be characterized at baseline, and after the four treatment conditions. This study will provide important information on three interventions for the most disabling sequelae of an enormous public health problem. Further, it will help to clarify underlying neural mechanisms and suggest additional treatment possibilities.
Contact Person: Jessica Bailey at firstname.lastname@example.org or 317-963-7516